US News & World Report:

A new study shows that giving men Gardasil is cost-effective and prevents throat cancer.

Controversy over the HPV vaccine has centered on its risks to girls and the idea that protecting them against cervical cancer could also lead them to experiment with sex at a younger age. But a new study underscores the effect of HPV on men, and points out that vaccinating men against the virus could prevent throat cancer as well.

About 9,300 men in the U.S. each year are affected by HPV-caused cancers, among them oropharyngeal cancer that occurs in the middle part of the throat behind the mouth and can develop around the tonsils and the back of the tongue. That number is expected to grow dramatically in the coming years.

“It is projected that by 2020, HPV-related oropharyngeal cancer will become the most common HPV-related cancer in the U.S., surpassing cervical cancer,” Dr. Donna Graham, a medical oncologist who led a new study on vaccination in men, said in a statement.

Read full article here.